Bright Minds Biosciences (DRUG) Other financing activities (2021 - 2026)
Bright Minds Biosciences (DRUG) reported Other financing activities of -$10.8 million for Q1 2026, down 2707.05% quarter-over-quarter from -$384445.0 in Q4 2025.
Bright Minds Biosciences (DRUG) Other financing activities (2021 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Other financing activities for 4 years, with the latest figure at -$10.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bright Minds Biosciences | 18.30 Bn | 18.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -384,445.02 |
| Dec 31, 2025 | -384,445.02 |
| Jun 30, 2025 | -120,843.54 |
| Jun 30, 2025 | -120,843.54 |
| Dec 31, 2024 | 59,930.89 |
| Dec 31, 2024 | 59,930.89 |
| Jun 30, 2021 | -19,037.35 |
| Jun 30, 2021 | -19,037.35 |